Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 5884-5888, November 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arlow, F. L.
Right arrow Articles by Majumdar, A. P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arlow, F. L.
Right arrow Articles by Majumdar, A. P. N.

Attenuation of Azoxymethane-induced Colonic Mucosal Ornithine Decarboxylase and Tyrosine Kinase Activity by Calcium in Rats1

Freda L. Arlow2, Steven M. Walczak, Gordon D. Luk and Adhip P. N. Majumdar

Veterans Administration Medical Center, Allen Park, Michigan 48101 [F. L. A., S. M. W., A. P. N. M.]; Division of Gastroenterology, Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201 [F. L. A., G. D. L., A. P. N. M.]; and Department of Nutrition and Food Science, Wayne State University, Detroit, Michigan 48202 [A. P. N. M.]

Two in vivo and one in vitro studies were performed to evaluate the chemoprotective role of calcium during the early period of azoxymethane (AOM) induction. In the first set of experiments, groups of male Fischer 344 rats were s.c. injected with either AOM (20 mg/kg) or water (controls) and sacrificed immediately (0 time), and 1, 3, 5, and 7 days postinjection. In the second set of experiments, animals were injected with the same dose of AOM and subsequently pair-fed with rat chow containing either calcium carbonate or diet devoid of added calcium. The amount of calcium consumed was calculated to be 250 mg/kg b.w. In both experiments, colonic mucosa was assayed for ornithine decarboxylase (ODC). In addition, tyrosine kinase (Tyr-k) activity as well as tyrosine specific phosphorylation of membrane proteins were determined. Results revealed that maximal stimulation by AOM of ODC and Tyr-k activity occurred 5 days postinjection. This stimulation was significantly suppressed by calcium. AOM also produced an increase in the rate of tyrosine specific phosphorylation of two distinct colonic mucosal membrane proteins with Mr of 57,000 and 59,000. Again, dietary calcium suppressed the stimulation.

In the third set of experiments, organ culture was utilized. Methylazoxymethanol, the active metabolite of AOM, was used instead of AOM in this part of study. Four hour exposure of mucosal explants to methylazoxymethanol (1 µg/ml) resulted in a significant (20–30%) increase in ODC and Tyr-k activity when compared to controls. Addition of either CaCl2 (2 µmol/ml) or difluoromethylornithine (2 nmol/ml) the irreversible inhibitor of ODC, significantly suppressed the methylazoxymethanol-induced activity of both ODC and Tyr-k.

We conclude that calcium may have a chemoprotective role and tyrosine kinases may have a regulatory role in the early stages of AOM induction of colon cancer.

1 Supported by the Veterans Administration Medical Research Service.

2 Present address: Henry Ford Hospital, Division of Gastroenterology, 2799 West Grand Boulevard, Detroit, Michigan 48202. To whom requests for reprints should be addressed, c/o A.P.N. Majumdar, Ph.D., D.Sc., at Research Service (151), VA Medical Center, Allen Park, Michigan 48101.

Received 1/20/89. Revised 7/14/89. Accepted 8/ 7/89.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
R. Jaszewski, A. Khan, F. H. Sarkar, O. Kucuk, M. Tobi, A. Zagnoon, R. Dhar, J. Kinzie, and A. P. N. Majumdar
Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines
Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1142 - C1148.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.